Which Patients With Early HCC Should Undergo Resection?
A recent meta-analysis suggests that liver resection may be more beneficial for patients with early-stage hepatocellular carcinoma (HCC) than previously thought. Traditionally, patients with multiple liver nodules were directed towards less invasive treatments like radiofrequency ablation and transarterial chemoembolization. The study emphasizes the importance of individual patient evaluation to determine the best treatment approach.
- ▪The meta-analysis included 15 studies and 2869 patients with multinodular early-stage HCC.
- ▪Results showed that liver resection had better overall survival and disease-free survival compared to RFA and TACE.
- ▪The study highlights the need for careful patient selection, particularly for those with good hepatic reserve.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/which-patients-early-hcc-should-undergo-resection-2026a1000hwk?src=rss |
| Publication time | Fri, 29 May 2026 03:15:59 EDT |
| Retrieval time | 2026-05-29T07:19:58.503Z |
| Last seen | 2026-05-29T07:19:58.503Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | PJDc5jiffDYy |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
For years, patients with early-stage hepatocellular carcinoma (HCC) who had multiple liver nodules were typically referred for less-invasive locoregional therapies such as radiofrequency ablation (RFA) and transarterial chemoembolization (TACE). The logic seemed sound: to avoid surgical trauma in people who often already have cirrhosis or limited liver function. Now, a new national multicenter meta-analysis suggests that, in carefully selected patients, this approach may need to be reconsidered.Published in the Journal of Liver Cancer, the study pooled 15 studies and 2869 patients with multinodular HCC classified as early-stage HCC — a group of individuals with multiple nodules still classified as having early-stage disease.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
